2023-10-03 08:41:53 ET
- Gainers: Alx Oncology ( ALXO ) +116% .
- Vericity ( VERY ) +95% Strengthens Individual Insurance Presence in the United States with the Acquisition of Vericity.
- POINT Biopharma Global ( PNT ) +85% to acquire Point Biopharma in $1.4B deal.
- SciSparc ( SPRC ) +42% granted European patent for its core technology.
- Delta Apparel ( DLA ) +17% .
- ODDITY ( ODD ) +16% .
- Ocean Biomedical ( OCEA ) +12% Announces Newly Published Findings Demonstrating Ability to Restore Treatment Sensitivity to AstraZeneca’s Leading Lung Cancer Drug After Resistance Has Formed, and Enhanced Tumor Suppression in EGFR-Mutation Lung Cancers.
- Lantheus ( LNTH ) +12% .
- ATAI Life Sciences ( ATAI ) +12% Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants.
- Lead Real Estate ( LRE ) +7% .
- Renalytix ( RNLX ) +7% .
- Cyteir Therapeutics ( CYT ) +7% FORM PREM14A | Proxy Statement - Merger or Acquistion (preliminary)
- PDS Biotechnology ( PDSB ) +6% Announces Interim 24-Month Survival Rate of 74% in Immune Checkpoint Inhibitor Naïve Head and Neck Cancer Patients Treated with PDS0101 in Combination with KEYTRUDA (pembrolizumab).
For further details see:
LNTH, ALXO and DLA are among pre market gainers